Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Repatha
Pharma
Sandoz, Henlius agree to $322M deal for 3 biosimilars
Sandoz has collaborated with Henlius to gain commercialization rights to three biosimilars for $100.5M up front and $322M if milestones are reached.
Kevin Dunleavy
Aug 17, 2026 10:46am
Amgen doesn't think Repatha's sales wins will stop anytime soon
Aug 4, 2026 4:01pm
FDA approves an oral PCSK9 med for 1st time in Merck's Lipfendra
Jul 16, 2026 9:30am
ADA: Amgen talks Repatha, GLP-1 hurdles as obesity plan advances
Jun 7, 2026 9:13pm
Repatha helps Amgen overcome Prolia's LOE freefall in Q1
May 1, 2026 8:18am
FDA endorses LIB's convenient cholesterol-lowering PCSK9 drug
Dec 15, 2025 11:33am
